ClinTec International Expands US Capabilities with the Launch of New York Office and Senior Business Operations Appointment
ClinTec International
has unveiled an expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
The expansion of US based operations through the launch of American headquarters, together with Susan Pavone’s appointment, will enable ClinTec to offer prospective US clients the chance to access global clinical research capabilities through a single partner.
President & CEO of ClinTec International, Dr Rabinder Buttar, commented: “We have established a strong presence in the international marketplace by placing clinical research staff in all key emerging, and established markets. The pharmaceutical industry is currently searching for new ways of working and delivering global solutions. ClinTec’s ability to harness global strength, coupled with local expertise, will be of great value to US pharmaceutical companies. Our new Associate Director of (US) Operations, Susan Pavone, has extensive knowledge of international clinical research and the new US facilities will prove an invaluable asset to American companies looking to tap into our globalised resources.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
